Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer.
Palazón-Carrión N, Jiménez-Cortegana C, Sánchez-León ML, Henao-Carrasco F, Nogales-Fernández E, Chiesa M, Caballero R, Rojo F, Nieto-García MA, Sánchez-Margalet V, de la Cruz-Merino L; Spanish Breast Cancer Group (GEICAM) and the Spanish Group for Immunobiotherapy of Cancer (GÉTICA).
Palazón-Carrión N, et al.
Sci Rep. 2021 Jul 13;11(1):14426. doi: 10.1038/s41598-021-93838-w.
Sci Rep. 2021.
PMID: 34257359
Free PMC article.